Cystic Fibrosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a confirmed diagnosis of cystic fibrosis (CF)
- People who are 18 years of age or older
- People whose estimated daily added sugar intake is more than 16 teaspoons, based on a dietary questionnaire completed during screening
Who may not be able to join:
- People who receive nutrition through a feeding tube at night
- People with a body mass index (BMI) below 18.5, which generally indicates being underweight
- People whose life expectancy is estimated to be less than 12 months
- People who have been diagnosed with cystic fibrosis-related diabetes (CFRD)
- People whose blood sugar level while fasting is found to be 126 mg/dL or higher during a screening glucose test
- People who use steroid medications on an ongoing, long-term basis
- People who are currently pregnant or breastfeeding
- People who are unwilling or unable to eat most of the foods provided as part of the study's meal plan
- People who have metal implants in their body that cannot be removed and are not compatible with MRI scanning
- People whose pancreatic digestive problems are not well managed and are causing significant malabsorption of nutrients
- People who have had recent changes to their medical treatment — including medications or a lung flare-up — within the 21 days before their study visit (confirm with trial site)
- People who started a CFTR modulator medication within the past 8 weeks, or whose weight or lung function has been unstable due to CFTR modulator use
- People who are actively working to gain or lose weight at the time of the study
- People who have food allergies or intolerances that the study team cannot accommodate within the meal plan
- People who have any other medical condition that a study doctor determines could prevent them from completing the study or could affect the study's results
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jessica A Alvarez, PhD, RD, Emory University
Phone: 404-727-1390
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in acute insulin response to arginine (AIRarg) from baseline; Change in acute C-peptide (ACRarg) from baseline; Change in visceral adipose tissue from baseline; Change in fasted plasma Eh[CySS] from baseline
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.